Testing the molecular profile of prostate tumours identifies which patients with advanced prostate cancer are more likely to benefit from a chemotherapy treatment called docetaxel and live longer, ...

Prostate cancer is the most common form of cancer among men in England, with cases surging by 25 per cent between 2019 and 2023, according to NHS data. It’s also the second-deadliest form of the ...

For men, a new urine test is improving prostate cancer detection. Men know about the PSA test but there's another test, the "mi-prostate score" or MIPS. It's been available since 2013. It combines PSA ...

Researchers identified three biomarkers that robustly detected the presence of prostate cancer Prostate biopsies after abnormal PSA blood test results are often negative and can result in unintended ...

Source: Getty Images Investigators analyzed exfoliated cells in urine specimens to identify 50 candidate RNAs for prostate cancer detection. Serum PSA testing is not specific to prostate cancer, and ...

DUBLIN and NEW YORK, March 23, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a global diagnostics company, today announced successful results from a clinical study of a new, enhanced ...

INDIANAPOLIS (WISH) — Prostate cancer remains a significant health concern, being the second leading cause of death among men, particularly affecting black men. Early detection of prostate cancer is ...

WASHINGTON - There's more advice on the contentious issue of prostate cancer screening: A leading group of cancer specialists says the decision hinges in part on a man's life expectancy. Doctors ...

The prostate health index (PHI) is a blood test that more accurately assesses the risk of prostate cancer than a traditional PSA test. The PHI combines three different PSA tests to create one risk ...

Testing the molecular profile of tumors identifies which patients with advanced prostate cancer are more likely to benefit from chemotherapy and live longer, sparing patients less likely to benefit ...